DCN and neoplasm: Moreover, the combination of an oncolytic adenovirus carrying DCN and chimeric antigen receptor T cells targeting carbonic anhydrase IX (CAIX-CAR-T) exhibited a significantly reduced tumor burden, enhanced interferon (IFN)-γ secretion, and prolonged mouse survival compared to the CAIX-CAR-T treatment control 57.